캐리어 스크리닝 시장 규모, 점유율, 성장 분석 : 검사 유형별, 질환 유형별, 병상별, 기술별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Carrier Screening Market Size, Share, and Growth Analysis, By Test Type, By Disease Type, By Medical Condition, By Technology, By End User, By Region - Industry Forecast 2025-2032
상품코드:1670170
리서치사:SkyQuest
발행일:2025년 02월
페이지 정보:영문 177 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 캐리어 스크리닝 시장 규모는 2023년에 25억 달러로 평가되며, 2024년 28억 3,000만 달러에서 2032년에는 76억 3,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 13.2%로 성장할 전망입니다.
유전성 질환의 발병률 증가와 예방적 헬스케어에 대한 관심이 높아짐에 따라 전 세계 보인자 선별검사 시장은 성장할 것으로 예상됩니다. 유전체 기술의 발전과 낭포성 섬유증, 테이삭스, 겸상 적혈구 빈혈과 같은 질병에 대한 인식이 높아짐에 따라 향후 수년간 보인자 선별 검사의 채택이 증가할 것으로 예상됩니다. 또한 유전자 검사에 대한 접근성이 개선되고, 유리한 상환 정책이 업계 관계자들에게 새로운 기회를 제공합니다. 그러나 표준화 부족, 신흥 시장에서의 낮은 인지도, 결과 해석의 복잡성, 고급 검사 기술에 따른 높은 비용 등의 문제는 2031년까지 시장 확대를 저해할 수 있습니다. 전반적으로 이 상황은 기술 혁신의 기회가 무르익은 상황이지만, 이해관계자들은 성장 기회를 활용하기 위해 이러한 장애물을 극복해야 합니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
캐리어 스크리닝 시장 규모 : 검사 유형별
시장 개요
분자 스크리닝 검사
생화학 스크리닝 검사
캐리어 스크리닝 시장 규모 : 질환 유형별
시장 개요
낭포성 섬유증
테이-삭스병
고셔병
겸상 적혈구증
척수성 근위축증
기타 상염색체 열성 유전성 질환
캐리어 스크리닝 시장 규모 : 병상별
시장 개요
폐질환
혈액 질환
신경질환
기타
캐리어 스크리닝 시장 규모 : 기술별
시장 개요
DNA 배열 해석
중합효소 연쇄 반응
마이크로어레이
기타
캐리어 스크리닝 시장 규모 : 최종사용자별
시장 개요
병원
표준실험실
의원, 진료소
기타
캐리어 스크리닝 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Illumina, Inc.(USA)
Thermo Fisher Scientific Inc.(USA)
Natera, Inc.(USA)
Myriad Genetics, Inc.(USA)
Eurofins Scientific(Luxembourg)
Laboratory Corporation of America Holdings(LabCorp)(USA)
Quest Diagnostics Incorporated(USA)
Invitae Corporation(USA)
PerkinElmer, Inc.(USA)
Fulgent Genetics(USA)
Agilent Technologies, Inc.(USA)
Genomics England(UK)
Centogene AG(Germany)
Integrated DNA Technologies, Inc.(IDT)(USA)
BGI Genomics(China)
Ambry Genetics Corporation(USA)
DNA Genotek Inc.(Canada)
GeneDx, Inc.(USA)
MedGenome Labs Pvt. Ltd.(India)
결론과 제안
KSA
영문 목차
영문목차
Global Carrier Screening Market size was valued at USD 2.5 billion in 2023 and is poised to grow from USD 2.83 billion in 2024 to USD 7.63 billion by 2032, growing at a CAGR of 13.2% during the forecast period (2025-2032).
The global carrier screening market is poised for growth, driven by the rising incidence of genetic diseases and an increasing focus on preventive healthcare. Advancements in genomic technologies and heightened awareness of disorders like cystic fibrosis, Tay-Sachs, and sickle cell anemia are expected to enhance the adoption of carrier screening in the coming years. Furthermore, improved accessibility to genetic testing and favorable reimbursement policies present new opportunities for industry players. However, challenges such as a lack of standardization, limited awareness in emerging markets, complexities in result interpretation, and the high costs associated with advanced testing technologies may hinder market progression through 2031. Overall, the landscape is ripe for innovation, but stakeholders must navigate these hurdles to capitalize on growth opportunities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Carrier Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Carrier Screening Market Segments Analysis
Global Carrier Screening Market is segmented by Test Type, Disease Type, Medical Condition, Technology, End User and region. Based on Test Type, the market is segmented into Molecular Screening Test and Biochemical Screening Test. Based on Disease Type, the market is segmented into Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease, Spinal Muscular Atrophy and Other Autosomal Recessive Genetic Disorders. Based on Medical Condition, the market is segmented into Pulmonary Conditions, Hematological Conditions, Neurological Conditions and Others. Based on Technology, the market is segmented into DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others. Based on End User, the market is segmented into Hospitals, Reference Laboratories, Physician Offices and Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Carrier Screening Market
The growing prevalence of genetic disorders acts as a significant catalyst for the Global Carrier Screening market. As more individuals and families become aware of the risks associated with hereditary conditions, the demand for carrier screening tests rises. This heightened awareness drives healthcare providers to prioritize genetic screening as a preventive measure, allowing for informed decision-making and risk assessment. Furthermore, advancements in genetic testing technologies and increasing accessibility to these services contribute to the market's expansion. Ultimately, the high incidence of genetic disorders emphasizes the importance of carrier screening, fostering growth and innovation within the industry.
Restraints in the Global Carrier Screening Market
One of the significant challenges facing the global carrier screening market is the lack of standardization in screening panels. This issue can lead to inconsistencies in test results and interpretations, which may cause confusion among healthcare providers and patients alike. The variability in testing methodologies and panel compositions across different laboratories can hinder the reliability and comparability of results. Additionally, the absence of a unified framework may create barriers to widespread adoption of carrier screening, as stakeholders may be uncertain about the effectiveness and relevance of various screening options. Addressing this lack of standardization is crucial for the market's growth and acceptance.
Market Trends of the Global Carrier Screening Market
The Global Carrier Screening market is witnessing a significant trend towards the integration of digital health solutions, which is poised to enhance patient engagement and streamline the screening process. As companies increasingly adopt digital platforms, the convenience and accessibility of carrier screening services are expected to attract a broader demographic, ultimately driving market growth. This convergence fosters a more personalized healthcare experience, encouraging more individuals to participate in screening initiatives. By leveraging technology, companies can not only expand their operational reach but also refine their service offerings, positioning themselves favorably in a rapidly evolving healthcare landscape.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Carrier Screening Market Size by Test Type & CAGR (2025-2032)
Market Overview
Molecular Screening Test
Biochemical Screening Test
Global Carrier Screening Market Size by Disease Type & CAGR (2025-2032)
Market Overview
Cystic Fibrosis
Tay-Sachs
Gaucher Disease
Sickle Cell Disease
Spinal Muscular Atrophy
Other Autosomal Recessive Genetic Disorders
Global Carrier Screening Market Size by Medical Condition & CAGR (2025-2032)
Market Overview
Pulmonary Conditions
Hematological Conditions
Neurological Conditions
Others
Global Carrier Screening Market Size by Technology & CAGR (2025-2032)
Market Overview
DNA Sequencing
Polymerase Chain Reaction
Microarrays
Others
Global Carrier Screening Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Reference Laboratories
Physician Offices and Clinics
Others
Global Carrier Screening Market Size & CAGR (2025-2032)
North America (Test Type, Disease Type, Medical Condition, Technology, End User)
US
Canada
Europe (Test Type, Disease Type, Medical Condition, Technology, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Test Type, Disease Type, Medical Condition, Technology, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Test Type, Disease Type, Medical Condition, Technology, End User)
Brazil
Rest of Latin America
Middle East & Africa (Test Type, Disease Type, Medical Condition, Technology, End User)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Illumina, Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Thermo Fisher Scientific Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Natera, Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Myriad Genetics, Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Eurofins Scientific (Luxembourg)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Laboratory Corporation of America Holdings (LabCorp) (USA)
